Bile Duct Cancer Market 2018 – Global Trend in Healthcare Industry by Top 10 Players Analysis and Forecasts Till 2023 | Asserts MRFR

Market Research Future published a Premium Research Report on “Global Bile Duct Cancer Market Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Pune, India - April 16, 2018 /MarketersMedia/ —

The Global Bile Duct Cancer Market is expected to grow at an approximate CAGR of 9.2% during the forecast period. Bile duct cancer or cholangiocarcinoma is a form of cancer in which epithelial cells are mutated, i.e., they show epithelial differentiation in the bile duct. It is a type of rare neoplasm. According to the National Cancer Institute, in 2014, there were an estimated 66,771 people living with liver and intrahepatic bile duct cancer in the United States. Moreover, the disease is expected to cause 28,920 deaths by the end of 2017 accounting for 4.8% of all cancer deaths. Rates for new liver and intrahepatic bile duct cancer cases have risen by an average 2.7% each year over the last 10 years. Death rates have been estimated to have risen by an average of 2.6% each year over 2005-2014. Such an increase in the prevalence of bile duct cancer has boosted the market. Additionally, rising healthcare expenditures, increasing awareness for the disease and investments in the R&D for treatment procedures is fuelling the market further. However, high cost of treatment and related side effects along with low healthcare expenditures in the developing economies is expected to restrain the market during the forecasted period.

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/4741 .

Key Players in the Bile Duct Cancer Market:

Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Europe), Bristol-Myers Squibb Company (U.S.), Teva Pharmaceutical Industries Ltd. (Isreal), Eli Lilly and Company. (U.S.), Sanofi (France), Fresenius Kabi AG (Germany), Mylan N.V. (U.S.), and others.

Bile Duct Cancer Market Regional Analysis:

The Americas dominates the global bile duct cancer market owing to a well-developed healthcare sector. Apart from this, increasing number of patients, increasing healthcare expenditure have boosted the growth of the market in the Americas. According to the Centers for Disease Control and Prevention, U.S. health care spending in 2015, reached $3.2 trillion or $9,990 per person which accounted for 17.8% of the total GDP.

Europe is the second largest bile duct cancer market, which is followed by Asia Pacific. Availability of funds for research, huge patient population and government support for research & development drives the European market.

Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India and China, and presence of huge opportunity in the market. According to Indian Brand Equity Fund, the per capita healthcare expenditure in India is estimated to grow at a CAGR of 5% during 2008-15 and reach USD 68.6 by 2015.

On the other hand, the Middle East & Africa has the least share in the global bile duct cancer market due to the presence of poor economy especially in Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.

Global Bile Duct Cancer Market Segmentation:

The Global Bile Duct Cancer Market is segmented on the basis of types, diagnosis, treatment, and end users.

On the basis of types, the market is segmented into intrahepatic, extrahepatic, and others.

On the basis of diagnosis, the market is segmented into blood tests, abdominal imaging, surgery, and others. The diagnosis segment by abdominal imaging is sub segmented into endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic cholangiography (PTC), magnetic resonance cholangiopancreatography (MRCP), and others.

On the basis of treatment, the market is segmented into chemotherapy, radiotherapy, and others. The chemotherapy segment is sub segmented into 5-fluorouracil, gemcitabine, cisplatin, and others.

On the basis of end users, the market is segmented into hospital &clinics, academic institutes, research organizations and others.

Get Discount @ https://www.marketresearchfuture.com/check-discount/4741 .

Major TOC Bile Duct Cancer Market Research Report – Global Forecast Till 2023:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

TOC Continued….!

LIST OF TABLES

Table 1 Bile Duct Cancer Industry Synopsis, 2017 – 2023

Table 2 Global Bile Duct Cancer Market Estimates And Forecast, 2017 – 2023, (USD Million)

Table 3 Global Bile Duct Cancer Market By Region, 2017 – 2023, (USD Million)

Table 4 Global Bile Duct Cancer Market By Types, 2017 – 2023, (USD Million)

Table 5 Global Bile Duct Cancer Market By Diagnosis, 2017 – 2023, (USD Million)

Table 6 Global Bile Duct Cancer Market By Treatment, 2017 – 2023, (USD Million)

Table 7 Global Bile Duct Cancer Market By End Users, 2017 – 2023, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Bile Duct Cancer Market

Figure 3 Segmentation Market Dynamics For Global Bile Duct Cancer Market

Figure 4 Global Bile Duct Cancer Market Share, By Type 2016

Figure 5 Global Bile Duct Cancer Market Share, By Diagnosis 2016

Figure 6 Global Bile Duct Cancer Market Share, By Treatment 2016

Figure 7 Global Bile Duct Cancer Market Share, By End Users, 2016

Ask to Expertise @ https://www.marketresearchfuture.com/enquiry/4741 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: sales@marketresearchfuture.com
Organization: Market Research Future
Address: Market Research Future, Office No. 528, Amanora Chambers, Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: 6468459312

Source URL: https://marketersmedia.com/bile-duct-cancer-market-2018-global-trend-in-healthcare-industry-by-top-10-players-analysis-and-forecasts-till-2023-asserts-mrfr/331637

For more information, please visit https://www.marketresearchfuture.com/reports/bile-duct-cancer-market-4741

Source: MarketersMedia

Release ID: 331637

More News From The Financial Capital

Chinese automaker plans electric car production in SAfrica

Apr 26, 2018

BEIJING — A state-owned Chinese automaker announced plans Wednesday to produce electric vehicles in South Africa, highlighting the growing role of the world's largest auto market in a technology seen as the global industry's future. BAIC Group's announcement at the Beijing auto show, the industry's biggest sales event of the year, came as Nissan unveiled its first electric car designed for China while General Motors displayed Buick SUV it says can go 600 kilometers (375 miles) on one charge. Chinese automaker Geely debuted a gasoline-electric hybrid developed with its Swedish sister company, Volvo Cars. Electrics are money-losers for most producers,...

HRW: 'Men only' job ads show ongoing discrimination in China

Apr 26, 2018

BEIJING — One job ad for Chinese high-speed train conductors called for candidates who were "fashionable and beautiful." Another ad targeting men for a job in a Chinese internet company included photos of a female employee pole-dancing. Gender discrimination is widespread in the Chinese workforce, a human rights group said Monday, with many hiring advertisements openly calling only for male applicants and using the attractiveness of female co-workers as a draw. Human Rights Watch released its report, "Only Men Need Apply: Gender Discrimination in Job Advertisements in China" after looking at more than 36,000 job advertisements posted between 2013 and...

Shanghai gets automated bank with VR, robots, face scanning

Apr 26, 2018

SHANGHAI — Missed paying dues on your Communist Party membership? There's a bank for that - and it's fully automated. A state-owned Chinese bank has opened an automated branch equipped with facial-scanning software, a virtual reality room, a hologram machine, talking robots and touchscreens for paying utility bills and Communist Party fees, among other functions. The branch opened last week in central Shanghai's Huangpu district and is being hyped as China's first "unmanned bank." Beijing-based China Construction Bank says the high-tech branch is meant to make banking more convenient, personalized, and efficient. It also reflects growing competition from cashless payment...

ZTE protests US penalty, says it is seeking solution

Apr 26, 2018

BEIJING — ZTE Corp., one of China's biggest tech companies, warned Friday a ban on access to U.S. technology threatens its survival and said the company is looking for a legal solution. State-owned ZTE "may enter a state of shock," which will hurt its employees and U.S. suppliers, its chairman said, according to Chinese news reports. A separate company statement said the ban "threatens ZTE's existence." The ban was imposed Monday in a case involving exports of telecoms equipment to Iran and North Korea. U.S. companies are barred from selling technology to ZTE for seven years. The penalty comes as...

As doors close in the US, China's Huawei shifts to Europe

Apr 26, 2018

SHENZHEN, China — As trade disputes simmer, Chinese telecommunications giant Huawei, the No. 3 smartphone brand, is shifting its growth efforts toward Europe and Asia in the face of mounting obstacles in the U.S. market. Shenzhen-based Huawei, the world's largest maker of telecoms equipment, has long coveted access to the U.S. but recently laid off key American employees at its Washington D.C. office. The U.S. has regularly stymied Huawei's efforts to enter the America, citing national security concerns. Huawei has failed to find a U.S. carrier to partner with for its smartphones, and the Federal Communications Commission on Tuesday approved...

Sign up now!

The Financial Capital is your independent source for finance information and advice. We provide insights and offer advice from financial experts so you can make the best decisions.

Contact us: sales[at]thefinancialcapital.com